Journal Article

Neurotrophic factor synergy is required for neuronal survival and disinhibited axon regeneration after CNS injury

Ann Logan, Zubair Ahmed, Andrew Baird, Ana Maria Gonzalez and Martin Berry

in Brain

Published on behalf of The Guarantors of Brain

Volume 129, issue 2, pages 490-502
Published in print February 2006 | ISSN: 0006-8950
Published online December 2005 | e-ISSN: 1460-2156 | DOI: http://dx.doi.org/10.1093/brain/awh706
Neurotrophic factor synergy is required for neuronal survival and disinhibited axon regeneration after CNS injury

Show Summary Details

Preview

The therapeutic effects of individual neurotrophic factors (NTF) have proved disappointing in clinical trials for neuronal repair and axon regeneration. Here, we demonstrate NTF synergistic neuronal responses after a combination of basic fibroblast growth factor, neurotrophin-3 and brain derived growth factor delivered to the somata of retinal ganglion cells promoted greater survival and axon growth than did the sum of the effects of each NTF alone. Triple and not single NTF treatments potentiated regulated intramembraneous proteolysis of p75NTR, and ectodomain shedding of Nogo receptor, correlated with a 30% decrease in activation of Rho-A, a key signalling molecule in the axon growth inhibitory cascade. Thus, combinatorial NTF administration synergistically enhanced neuronal survival, disinhibited axon growth and promoted axon regeneration through the hostile CNS environment without the intervention of scar tissue at the lesion site.

Keywords: Neurotrophic factors; regulated intramembrane proteolysis; optic nerve regeneration; p75NTR; CNS; BDNF = brain derived neurotrophic factor; FGF2 = fibroblast growth factor; NT-3 = neurotrophin-3; NgR = Nogo receptor

Journal Article.  8254 words.  Illustrated.

Subjects: Neurology ; Neuroscience

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.